Speciality Medicines Limited β Pembrolizumab Exporter Profile
Indian Pharmaceutical Exporter Β· #7 for Pembrolizumab Β· $159.1K export value Β· DGFT Verified
Speciality Medicines Limited is the #7 Indian exporter of Pembrolizumab with $159.1K in export value and 20 verified shipments. Speciality Medicines Limited holds a 8.2% market share in Pembrolizumab exports across 2 countries. The company exports 6 pharmaceutical products worth $345.1K across 2 therapeutic categories.
Speciality Medicines Limited β Pembrolizumab Export Profile: Buyers & Destinations

Where Does Speciality Medicines Limited Export Pembrolizumab?
| Country | Value | Shipments | Share |
|---|---|---|---|
| BRAZIL | $285.4K | 34 | 89.5% |
| ST KITTS-NEVIS-ANGUILLA | $19.7K | 2 | 6.2% |
| LITHUANIA | $13.7K | 3 | 4.3% |
Speciality Medicines Limited exports Pembrolizumab to 3 countries. The largest destination is BRAZIL accounting for 89.5% of Speciality Medicines Limited's Pembrolizumab shipments, followed by ST KITTS-NEVIS-ANGUILLA (6.2%) and LITHUANIA (4.3%). These destinations reflect Speciality Medicines Limited's established distribution network and regulatory approvals in key markets.